Earnings calls

Suraksha Diagnostic Limited concall ledger

Every earnings call for SURAKSHA — management tone, guidance, KPIs and promise tracking, quarter by quarter.

SURAKSHA · 5 transcripts · Healthcare · latest Q4 FY26

Suraksha Diagnostic Limited has 5 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

Q4 FY26Published 22 May 2026Call held 22 May 2026

SURAKSHA Q4 FY26 Earnings Call Transcript & Analysis

Revenue3,136 million+23% YoYEBITDA986 million+16% YoYEBITDA Margin31.8%PAT314 million+1% YoYPAT Margin10.1%

Revenue (FY26) 3136 million (+22% YoY); EBITDA (FY26) 986 million (+16% YoY); EBITDA Margin (FY26) 31.8%. FY26 Revenue from operations stood at INR3104.1 million, representing a robust 23.1% YoY growth.

Read full transcript & analysis

Q3 FY26Published 06 Feb 2026Call held 06 Feb 2026

SURAKSHA Q3 FY26 Earnings Call Transcript & Analysis

EBITDA237.82 million+26% YoYEBITDA Margin30.6%PAT72.41 millionPAT Margin9.3%Total Income783.09 million+30% YoY

EBITDA (Q3 FY26) 237.82 million (+26% YoY); EBITDA Margin (Q3 FY26) 30.6%; PAT (Q3 FY26) 72.41 million. Total income grew 30.3% YoY to INR 783.09 million in Q3 FY26.

Read full transcript & analysis

Q2 FY26Published 11 Nov 2025Call held 11 Nov 2025

SURAKSHA Q2 FY26 Earnings Call Transcript & Analysis

Q2 Revenue₹79.58 cr+17% YoYQ2 EBITDA₹24.966 cr+2% YoYQ2 EBITDA Margin31.7%Q2 PAT₹8.828 cr−13% YoYQ2 PAT Margin11.2%

Q2 Revenue ₹80 cr (+17% YoY); Q2 EBITDA ₹25 cr (+2% YoY); Q2 EBITDA Margin 31.7%. Q2 FY26 total income grew 16.9% YoY to INR79.58 crores.

Read full transcript & analysis

Q1 FY26Published 11 Aug 2025Call held 11 Aug 2025

SURAKSHA Q1 FY26 Earnings Call Transcript & Analysis

EBITDA₹24.656 cr+14% YoYEBITDA Margin33.97%PAT₹9.175 cr+20% YoYPAT Margin12.64%Total Income₹73.492 cr+19% YoY

EBITDA ₹25 cr (+14% YoY); EBITDA Margin 33.97%; PAT ₹9 cr (+20% YoY). Total income grew 18.83% YoY to ₹73.49 crores.

Read full transcript & analysis

Q4 FY25Published 30 May 2025Call held 30 May 2025

SURAKSHA Q4 FY25 Earnings Call Transcript & Analysis

EBITDA₹85.09 cr+16% YoYEBITDA Margin34%PAT₹30.98 cr+34% YoYPAT Margin12.3%Total Income₹255.94 cr+15% YoY

EBITDA (FY25) ₹85 cr (+16% YoY); EBITDA Margin (FY25) 34.0%; PAT (FY25) ₹31 cr (+34% YoY). FY25 Total Income grew 15% YoY to ₹255.94 crores.

Read full transcript & analysis